Results 201 to 210 of about 567,812 (303)
Planos diretores participativos e gestão urbana em cidades médias sob o estatuto da cidade
Eliana Tadeu Terci +2 more
openalex +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
[Otitis media due to Vibrio cholerae non-O1/O139: A case report and short review]. [PDF]
Regalado Bermeo DF +2 more
europepmc +1 more source
Formation d’opinion par les médias, bien ou mal pour les politiques de santé
Ştefania Bejan
openalex +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Awareness, Knowledge, Attitude, and Source of Information on HIV Infection Among College Students. [PDF]
Zheng C +5 more
europepmc +1 more source
GESTÃO DA INFORMAÇÃO EM PEQUENAS E MÉDIAS EMPRESAS
Eliane Pawlowski de Oliveira Araújo +2 more
openalex +1 more source
Des principes éthiques pour éduquer aux médias et à l’information et limiter les situations de harcèlement [PDF]
Sylvie CONDETTE
openalex +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

